SGD has a significant regulatory effect on neuropathic pain, can increase the pain threshold, and reduce the levels of SP, - EP, PGE2 and NO
An oral product avoids injection-site pain, bruising and the low risk of anaphylaxis
That observation, while from an in vitro model, anchors the theoretical basis for every clinical protocol in use today
This distinction matters for researchers because the two pathways are synergistic which is why CJC-1295 + Ipamorelin combinations are so widely studied
(silymarin) extract supplementation on antioxidant status and hs-CRP in patients with type 2 diabetes mellitus: a randomized, triple-blind, placebo-controlled clinical trial
Iranian journal of kidney diseases 5, 114118 (2011)